HOUSE BILL 729
J1 5lr2551
CF SB 594
By: Delegate Rosenberg Delegates Rosenberg, Pena–Melnyk, Chisholm, Cullison,
Bagnall, Bhandari, Guzzone, Hill, S. Johnson, Kaiser, Kerr, Kipke, Lopez,
Martinez, Taveras, White Holland, Woods, and Woorman
Introduced and read first time: January 27, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: February 25, 2025
CHAPTER ______
1 AN ACT concerning
2 Public Health – Use of Opioid Restitution Fund and Training Under the
3 Overdose Response Program
4 FOR the purpose of altering the training that the Maryland Department of Health is
5 authorized to provide under the Overdose Response Program; clarifying that the use
6 of the Opioid Restitution Fund is subject to certain restrictions; altering the
7 authorized uses of the Opioid Restitution Fund; and generally relating to the Opioid
8 Restitution Fund and the Overdose Response Program.
9 BY repealing and reenacting, without amendments,
10 Article – Health – General
11 Section 13–3101(a) and (d)
12 Annotated Code of Maryland
13 (2023 Replacement Volume and 2024 Supplement)
14 BY repealing and reenacting, with amendments,
15 Article – Health – General
16 Section 13–3103(b)
17 Annotated Code of Maryland
18 (2023 Replacement Volume and 2024 Supplement)
19 BY repealing and reenacting, without amendments,
20 Article – State Finance and Procurement
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb0729*

2 HOUSE BILL 729
1 Section 7–331(a) through (e)
2 Annotated Code of Maryland
3 (2021 Replacement Volume and 2024 Supplement)
4 BY repealing and reenacting, with amendments,
5 Article – State Finance and Procurement
6 Section 7–331(f)
7 Annotated Code of Maryland
8 (2021 Replacement Volume and 2024 Supplement)
9 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
10 That the Laws of Maryland read as follows:
11 Article – Health – General
12 13–3101.
13 (a) In this subtitle the following words have the meanings indicated.
14 (d) “Program” means the Overdose Response Program.
15 13–3103.
16 (b) The Department may:
17 (1) Collect fees necessary for the administration of the Program;
18 (2) Authorize private or public entities to conduct education and training
19 on opioid overdose recognition and response that include:
20 (i) Education on recognizing the signs and symptoms of an opioid
21 overdose;
22 (ii) Training on responding to an opioid overdose, including the
23 administration of opioid overdose reversal drugs approved by the federal Food and Drug
24 Administration, EMPHASIZING THE RESTORATION OF BREATHING, AVOIDING
25 WITHDRAWAL, AND COMPASSIONATE POSTOVERDOSE SUPPORT AND CARE; and
26 (iii) Access to opioid overdose reversal drugs approved by the federal
27 Food and Drug Administration and the necessary supplies for the administration of the
28 opioid overdose reversal drugs;
29 (3) Develop guidance regarding the content of educational training
30 programs conducted by private or public entities; and
31 (4) Collect and report data on the operation and results of the programs.

HOUSE BILL 729 3
1 Article – State Finance and Procurement
2 7–331.
3 (a) In this section, “Fund” means the Opioid Restitution Fund.
4 (b) There is an Opioid Restitution Fund.
5 (c) The purpose of the Fund is to retain the amount of settlement revenues
6 deposited to the Fund in accordance with subsection (e)(1) of this section.
7 (d) (1) The Fund is a special, nonlapsing fund that is not subject to § 7–302 of
8 this subtitle.
9 (2) The State Treasurer shall hold the Fund separately, and the
10 Comptroller shall account for the Fund.
11 (e) The Fund consists of:
12 (1) all revenues received by the State from any source resulting, directly or
13 indirectly, from any judgment against, or settlement with, opioid manufacturers, opioid
14 research associations, or any other person in the opioid industry relating to any claims
15 made or prosecuted by the State to recover damages for violations of State law; and
16 (2) the interest earnings of the Fund.
17 (f) The Fund may be used only to provide funds for THE PURPOSES SPECIFIED
18 IN SETTLEMENT AGREEMENTS AND JUDGMENTS RELATING TO CLAIMS BY THE
19 STATE AGAINST OPIOID MANUFACTURERS, OPIOID RESEARCH ASSOCIATIONS, OR
20 ANY OTHER PERSON IN THE OPIOID INDUSTRY FOR VIOLATIONS OF STATE LAW,
21 INCLUDING:
22 (1) programs, services, supports, and resources for evidence–based
23 substance use disorder prevention, treatment, recovery, or harm reduction that have the
24 purpose of:;
25 (i) improving access to medications proven to prevent or reverse an
26 overdose, including by supporting the initiative to co–locate naloxone with automated
27 external defibrillators placed in public buildings under § 13–518 of the Education Article;
28 (ii) supporting peer support specialists and screening, brief
29 intervention, and referral to treatment services for hospitals, correctional facilities, and
30 other high–risk populations;
31 (iii) increasing access to medications that support recovery from
32 substance use disorders; AND

4 HOUSE BILL 729
1 (iv) expanding the Heroin Coordinator Program, including for
2 administrative expenses;
3 [(v) expanding access to crisis beds and residential treatment
4 services for adults and minors;
5 (vi) expanding and establishing safe stations, mobile crisis response
6 systems, and crisis stabilization centers;
7 (vii) supporting the behavioral health crisis hotline;
8 (viii) organizing primary and secondary school education campaigns
9 to prevent opioid use, including for administrative expenses;
10 (ix) enforcing the laws regarding opioid prescriptions and sales,
11 including for administrative expenses;
12 (x) research regarding and training for substance use treatment and
13 overdose prevention, including for administrative expenses; and
14 (xi) supporting and expanding other evidence–based interventions
15 for overdose prevention and substance use treatment;]
16 (2) supporting community–based nonprofit recovery organizations that
17 provide nonclinical substance use recovery support services in the State;
18 (3) ADDRESSING RACIAL DISPARITIES IN ACCESS TO PREVENTION,
19 HARM REDUCTION, TREATMENT, AND RECOVERY SUPPORT SERVICES;
20 (4) ADDRESSING SOCIOECONOMIC DISPARITIES IN ACCESS TO
21 PREVENTION, HARM REDUCTION, TREATMENT, AND RECOVERY SUPPORT SERVICES;
22 (5) evidence–informed substance use disorder prevention, treatment
23 recovery, or harm reduction pilot programs or demonstration studies that are not
24 evidence–based if the Opioid Restitution Fund Advisory Council, established under §
25 7.5–902 of the Health – General Article:
26 (i) determines that emerging evidence supports the distribution of
27 money for the pilot program or that there is a reasonable basis for funding the
28 demonstration study with the expectation of creating an evidence–based program; and
29 (ii) approves the use of money for the pilot program or demonstration
30 study; and

HOUSE BILL 729 5
1 [(4)] (5) (6) evaluations of the effectiveness and outcomes reporting for
2 substance use disorder abatement infrastructure, programs, services, supports, and
3 resources for which money from the Fund was used, including evaluations of the impact on
4 access to harm reduction services or treatment for substance use disorders and the
5 reduction in drug–related mortality.
6 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July
7 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      5   C A P O F t p o a t t t t M D o H i a o t O R F i s t c r a t a R B  A S  A  ( B  A S  A  ( B  A]
[DELETED:  H  S  A  ( B  A S  A  (  S T A 1  ( I  ( “ 1  ( T   ( C   ( A o    ( E o    ( T o r t a o o i t a AE T R O BG AL  ;    ( A F o   ( D g r t c o e t p   ( C]
[DELETED: H 3 A 7  ( I  ( T  ( T p o t F i t r t a o s r d  ( ( T t   ( T S T s h t F s a t C  ( T   ( a i r m   ( t  ( T S A A J R T C B T,S S  O P I T O I F V O T LW :   ( p s s a r f e s p:    ( i o i b s t i t c n w a e    ( s p s s a s b i o    ( i a t m t s r f s ]
[DELETED:  H     ( e t H C P i f a    ( e a t c b a r t s    ( e s    ( s    ( o t    ( e t l r o p a s i    ( r o    ( s a e o e i f;   ( s c n r o t p   ( R D I A T PNN T ,    S D I A TN N T ,,;    e s u d p t r o h r p p o d s t a n e i t O R F A C e u § 7    ( d m f t p p o t t i a r b f f t d    ( a s]
[DELETED: H 5   ()  e o t e a o r f]()( s u d a i p s s a r a t h r s o t f s u d a t r  S 1          G               ]